Andra Ap Fonden Incyte Corp Transaction History

Andra Ap Fonden

$5.86 Billion
Q1 2025

A detailed history of Andra Ap Fonden transactions in Incyte Corp stock. As of the latest transaction made, Andra Ap Fonden holds 332,300 shares of INCY stock, worth $23.3 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares

332,300

Previous 212,500 56.38%

Holding current value

$23.3 Million

Previous $14.7 Million 37.09%

% of portfolio

0.34%

Previous 0.25%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$60.0 - $75.26 $7.19 Million - $9.02 Million	119,800 Added 56.38%	332,300 $20.1 Million
Q4 2024 Feb 07, 2025	BUY	$65.08 - $83.38 $1.01 Million - $1.29 Million	15,500 Added 7.87%	212,500 $14.7 Million
Q3 2024 Nov 12, 2024	SELL	$57.33 - $68.61 $2.91 Million - $3.49 Million	-50,800 Reduced 20.5%	197,000 $13 Million
Q2 2024 Aug 07, 2024	BUY	$51.18 - $63.75 $3.3 Million - $4.11 Million	64,500 Added 35.19%	247,800 $15 Million
Q1 2024 May 13, 2024	SELL	$56.55 - $66.59 $401,505 - $472,789	-7,100 Reduced 3.73%	183,300 $10.4 Million
Q4 2023 Feb 15, 2024	BUY	$52.16 - $64.19 $2.65 Million - $3.27 Million	50,900 Added 36.49%	190,400 $12 Million
Q3 2023 Nov 09, 2023	SELL	$57.77 - $65.93 $618,139 - $705,451	-10,700 Reduced 7.12%	139,500 $8.06 Million
Q2 2023 Aug 09, 2023	BUY	$60.95 - $75.51 $1.4 Million - $1.73 Million	22,900 Added 17.99%	150,200 $9.35 Million
Q1 2023 May 12, 2023	BUY	$70.23 - $86.01 $1.64 Million - $2.01 Million	23,400 Added 22.52%	127,300 $9.2 Million
Q4 2022 Feb 13, 2023	SELL	$67.18 - $84.11 $859,904 - $1.08 Million	-12,800 Reduced 10.97%	103,900 $8.35 Million
Q3 2022 Nov 14, 2022	BUY	$66.18 - $82.86 $1.5 Million - $1.88 Million	22,700 Added 24.15%	116,700 $7.78 Million
Q2 2022 Aug 15, 2022	SELL	$66.18 - $83.18 $615,474 - $773,574	-9,300 Reduced 9.0%	94,000 $7.14 Million
Q4 2021 Feb 15, 2022	BUY	$63.34 - $74.11 $905,762 - $1.06 Million	14,300 Added 16.07%	103,300 $7.58 Million
Q3 2021 Nov 12, 2021	SELL	$68.67 - $84.02 $254,079 - $310,874	-3,700 Reduced 3.99%	89,000 $6.12 Million
Q2 2021 Aug 16, 2021	BUY	$79.87 - $87.53 $3.24 Million - $3.55 Million	40,600 Added 77.93%	92,700 $7.8 Million
Q1 2021 May 17, 2021	SELL	$76.02 - $100.5 $387,702 - $512,550	-5,100 Reduced 8.92%	52,100 $4.23 Million
Q4 2020 Feb 12, 2021	BUY	$80.74 - $97.7 $1.66 Million - $2.01 Million	20,600 Added 56.28%	57,200 $4.98 Million
Q3 2020 Nov 12, 2020	SELL	$85.07 - $109.69 $1.54 Million - $1.99 Million	-18,100 Reduced 33.09%	36,600 $3.28 Million
Q2 2020 Aug 06, 2020	SELL	$74.18 - $108.93 $1.17 Million - $1.72 Million	-15,800 Reduced 22.41%	54,700 $5.69 Million
Q1 2020 May 13, 2020	BUY	$63.18 - $85.97 $644,436 - $876,894	10,200 Added 16.92%	70,500 $5.16 Million
Q4 2019 Feb 10, 2020	BUY	$73.04 - $95.72 $635,448 - $832,764	8,700 Added 16.86%	60,300 $5.27 Million
Q3 2019 Nov 19, 2019	SELL	$72.82 - $86.52 $240,305 - $285,516	-3,300 Reduced 6.01%	51,600 $3.83 Million
Q2 2019 Aug 15, 2019	BUY	$73.52 - $88.7 $95,576 - $115,310	1,300 Added 2.43%	54,900 $4.66 Million
Q1 2019 May 14, 2019	BUY	$63.56 - $88.17 $19,068 - $26,451	300 Added 0.56%	53,600 $4.61 Million
Q3 2018 Oct 16, 2018	SELL	$61.75 - $74.23 $864,500 - $1.04 Million	-14,000 Reduced 20.8%	53,300 $3.68 Million
Q2 2018 Aug 17, 2018	BUY	$60.85 - $83.98 $1.45 Million - $2.01 Million	23,900 Added 55.07%	67,300 $4.51 Million
Q1 2018 Apr 10, 2018	BUY	$83.06 - $100.98 $3.06 Million - $3.72 Million	36,800 Added 557.58%	43,400 $3.62 Million
Q4 2017 Feb 14, 2018	BUY	$93.56 - $116.6 $84,204 - $104,940	900 Added 15.79%	6,600 $625,000
Q3 2017 Oct 31, 2017	BUY	$109.15 - $138.27 $622,155 - $788,139	5,700	5,700 $665,000

Others Institutions Holding INCY

# of Institutions

695

Shares Held

194M

Call Options Held

564K

Put Options Held

331K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.6B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Andra Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Andra Ap Fonden with notifications on news.

Account